Nuclear Medicine and Biology

Elsevier BV

Journal websitePeer review: Peer review
Evaluation status available after sign-in

About the journal

Nuclear Medicine and Biology is a journal published by Elsevier BV in United Kingdom. It is listed in MEDLINE according to the sources read. Declared publication charge: 3,270 USD. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
Elsevier BV
ISSN
1872-9614 · 0969-8051
Country
United Kingdom
Access
Not open access / not declared
Declared publication charge
3,270 USD
Declared peer-review model
peer_review

Index listings

  • MEDLINE · 1993-01-01
Indexing
MEDLINE
APC
3,270 USD
Declared review time (DOAJ)
—
Actual review time (measured)
90 days received→accepted — computed from PubMed (n=98)
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Works in OpenAlex

6230

Last recorded publication year

2026

Reported by OpenAlex in 1 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

109

i10-index

2503

From OpenAlex open data (CC0).

Editorial & policy4
Observed digital preservation (Keepers registry)— snapshot 2026-10-05
CLOCKSSPortico
Norwegian register (HK-dir)— 2026
Level 1 — approved scholarly channel
Open references deposited at Crossref
27%
ORCID iDs in current deposits
2%
Deposits licence metadata at Crossref
✓
Identity & continuity4
Alternate titles
NMB
Source type
journal
NLM unique ID (PubMed)
9304420
Classification(no data)

No data available to the platform for this group

No platform data for: Classification — absence is not a judgment about the journal.

Subject areas

  • Radiopharmaceutical Chemistry and Applications
  • Radiopharmaceutical Chemistry and Applications
  • Medical Imaging Techniques and Applications
  • Medical Imaging Techniques and Applications
  • Peptidase Inhibition and Analysis
  • Peptidase Inhibition and Analysis
  • Medical Imaging and Pathology Studies
  • Medical Imaging and Pathology Studies
Show all subjects (50)
  • Monoclonal and Polyclonal Antibodies Research
  • Monoclonal and Polyclonal Antibodies Research
  • Neuroscience and Neuropharmacology Research
  • Neuroscience and Neuropharmacology Research
  • Cancer, Hypoxia, and Metabolism
  • Cancer, Hypoxia, and Metabolism
  • Lanthanide and Transition Metal Complexes
  • Lanthanide and Transition Metal Complexes
  • Diverse Scientific and Economic Studies
  • Diverse Scientific and Economic Studies
  • Neurotransmitter Receptor Influence on Behavior
  • Neurotransmitter Receptor Influence on Behavior
  • Chemical Reactions and Isotopes
  • Chemical Reactions and Isotopes
  • Receptor Mechanisms and Signaling
  • Receptor Mechanisms and Signaling
  • Neuroendocrine Tumor Research Advances
  • Neuroendocrine Tumor Research Advances
  • Prostate Cancer Treatment and Research
  • Prostate Cancer Treatment and Research
  • Amino Acid Enzymes and Metabolism
  • Amino Acid Enzymes and Metabolism
  • Human auditory perception and evaluation
  • Human auditory perception and evaluation
  • Glioma Diagnosis and Treatment
  • Glioma Diagnosis and Treatment
  • Educational Robotics and Engineering
  • Educational Robotics and Engineering
  • HER2/EGFR in Cancer Research
  • HER2/EGFR in Cancer Research
  • Orthopedic Infections and Treatments
  • Orthopedic Infections and Treatments
  • Cell Adhesion Molecules Research
  • Fluorine in Organic Chemistry
  • Fluorine in Organic Chemistry
  • Cell Adhesion Molecules Research
  • Pharmacological Receptor Mechanisms and Effects
  • Pharmacological Receptor Mechanisms and Effects
  • Nanoplatforms for cancer theranostics
  • Nanoplatforms for cancer theranostics
  • Drug Transport and Resistance Mechanisms
  • Drug Transport and Resistance Mechanisms

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: